Diagnostic endoscopic submucosal dissection for colorectal lesions with suspected deep invasion
Endoscopy · 01.02.2023 · 55 (02) · 192-197
DOI: 10.1055/a-1866-8080 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Endoscopy, erschienen am 01.02.2023. Verfasst von Adrien Patenotte und 16 weiteren Autor:innen. Beteiligte Einrichtung: Endoscopy and Gastroenterology Unit, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Endoscopic Mucosal Resection. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Background
Endoscopic submucosal dissection (ESD) is potentially a curative treatment for T1 colorectal cancer under certain conditions. The aim of this study was to evaluate the feasibility and effectiveness of ESD for lesions with a suspicion of focal deep invasion.
Methods
In this retrospective multicenter study, consecutive patients with colorectal neoplasia displaying a focal (< 15 mm) deep invasive pattern (FDIP) that were treated by ESD were included. We excluded ulcerated lesions (Paris III), lesions with distant metastasis, and clearly advanced tumors (tumoral strictures).
Results
124 patients benefited from 126 diagnostic dissection attempts for FDIP lesions. Dissection was feasible in 120/126 attempts (95.2 %) and, where possible, the en bloc and R0 resection rates were 95.8 % (115/120) and 76.7 % (92/120), respectively. Thirty-three resections (26.2 %) were for very low risk tumors, so considered curative, and 38 (30.2 %) were for low risk lesions. Noncurative R0 resections were for lesions with lymphatic or vascular invasion (LVI; n = 8), or significant budding (n = 9), and LVI + budding combination (n = 4).
Conclusion
ESD is feasible and safe for colorectal lesions with an FDIP ≤ 15 mm. It was curative in 26.6 % of patients and could be a valid option for a further 30.6 % of patients with low risk T1 cancers, especially for frail patients with co-morbidities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Endoscopy and Gastroenterology Unit, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France.
- Endoscopy and Gastroenterology Unit, Pontchaillou University Hospital, Rennes, France.
- Service de Biostatistique, Hospices Civils de Lyon and CNRS, Laboratoire de Biométrie et Biologie Évolutive UMR 5558, Université Claude Bernard Lyon 1, Universités de Lyon, Lyon, France.
- Department of Endoscopy and Gastroenterology, Hôpital Privé Jean Mermoz, Lyon, France.
- Endoscopy and Gastroenterology Unit, Brabois Hospitals, Nancy, France.
- Institute of Pathology - East site, Groupement hospitalier Est, Hospices Civils de Lyon, Lyon, France.
ORCID-Profile: Pierre Lafeuille
Zitieren
APA
Patenotte, A., Yzet, C., Wallenhorst, T., Subtil, F., Leblanc, S., Schaefer, M., Walter, T., Lambin, T., Fenouil, T., Lafeuille, P., Chevaux, J. B., Legros, R., Rostain, F., Rivory, J., Jacques, J., Lépilliez, V., & Pioche, M. (2023). Diagnostic endoscopic submucosal dissection for colorectal lesions with suspected deep invasion. Endoscopy, 55(02), 192-197. https://doi.org/10.1055/a-1866-8080
Vancouver
Patenotte A, Yzet C, Wallenhorst T, Subtil F, Leblanc S, Schaefer M, et al. Diagnostic endoscopic submucosal dissection for colorectal lesions with suspected deep invasion. Endoscopy. 2023;55(02):192-197. doi:10.1055/a-1866-8080
BibTeX
@article{Patenotte2023,
author = {Patenotte, Adrien and Yzet, Clara and Wallenhorst, Timothée and Subtil, Fabien and Leblanc, Sarah and Schaefer, Marion and Walter, Thomas and Lambin, Thomas and Fenouil, Tanguy and Lafeuille, Pierre and Chevaux, Jean-Baptiste and Legros, Romain and Rostain, Florian and Rivory, Jérôme and Jacques, Jérémie and Lépilliez, Vincent and Pioche, Mathieu},
title = {Diagnostic endoscopic submucosal dissection for colorectal lesions with suspected deep invasion},
journal = {Endoscopy},
year = {2023},
volume = {55},
number = {02},
pages = {192--197},
doi = {10.1055/a-1866-8080}
}
EUVIMED